We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO International ConventionJune 3-6, 2019
BIO World Congress on Industrial Biotechnology and Ag TechJuly 8-11, 2019
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
February 11 - 12, 2019 | New York, New York
Sensei Biotherapeutics is an innovator in the field of next-generation cancer immunotherapies, including cancer vaccines and T-cell therapies. We are pioneering the development of precision therapeutics that target ASPH, a powerful, uniquely human, tumor-specific antigen to treat cancer. SNS-301, our lead program, is a first-in-class cancer immunotherapy and has successfully completed a Phase 1 clinical study with plans for further clinical development in hematological malignancies and solid tumors.